Arizona Recount Milestone; Jordan: 'Worst' Presidential Start; NYC Is Rotting

 ‌

Breaking News from Newsmax.com Arizona Audit of 2020 Election Hits Hand-Count Milestone Special: The Rise of Parkinson's Disease Is a Disturbing Trend in Global Health Jim Jordan to Newsmax: Start of Biden Presidency, 'Worst' in a Lifetime Journalist Seth Barron to Newsmax: New York City Is Rotting SPONSOR   The Rise of Parkinson's Disease is a Disturbing Trend in Global Health  Following Alzheimer's disease, Parkinson's disease (PD) is the second-most common neurodegenerative disease in the United States. According to Dr. Ray Dorsey, a neurologist at the University of Rochester Medical Center, "Parkinson's is the fastest-growing neurological disorder in the world. In the United States, the number of people with Parkinson's has increased 35% in the last 10 years".  This company's subsidiary developed a generic transdermal form of dopamine treatment for Parkinson's. This patch, similar to a nicotine patch, can help ease motor symptoms of Parkinson's, and potentially help with several non-motor symptoms.  Let us explain: Parkinson's disease is a disorder of the nervous system that causes difficulties with movement, muscle control, and balance. Non-motor-related symptoms include cognitive impairment, mood and behavioral problems, sleep disorders, and constipation.  The National Institute of Neurological Disorders and Stroke (NINDS) estimates that nearly 500,00 Americans have been diagnosed with the disease. Some experts believe the number is closer to one million due to undiagnosed individuals. The NINDS estimates that the cost of treating PD is approximately $14 billion annually with indirect costs estimated conservatively at $6.3 billion.  Basically, our nervous system is made up of individual cells which serve as a "communication network". Neurons use chemical messengers called neurotransmitters. In this case, dopamine is the critical agent that transmits messages from the brain to the muscle. PD impacts the body's ability to generate this substance. Muhammed Ali and, Michael J. Fox, and Robin Williams are just a few names to see their quality of life destroyed by this terrible disease. This company 'has developed a generic transdermal patch- a drug delivery system that is applied directly to the skin- that has been used worldwide as an alternative to conventional oral treatment. The patch activates dopamine receptors. Once administered, it can bind the receptors to the brain and mimic the action of dopamine. This company received encouraging study results for its patch development program. It will advance the trial studies to pivotal human tests. Results are expected by the end of the year. The company has embarked on the development of a started ramping up commercial production facilityies to meet anticipated demand. This company is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities. The company focuses on precision transdermal and oral dissolvable drug formulations, low-cost infectious diseases, and oral health screening tests, emerging active pharmaceutical ingredients for neurological applications including psychedelic and cannabis compounds.  The generic drug delivery model represents a major opportunity for scalable value creation through expedited clinical evaluation and product launch.  Click here to learn more about this company's PD treatments and other opportunities it is pursuing in the pharmaceutical space.  More About Emerging Markets, LLC. For more informative reports such as this, please sign up so we may keep you informed. About Emerging Markets Consulting LLC Based in Orlando, Florida, Emerging Markets Consulting, LLC (EMC) brings multiple decades of combined experience in the investor relations industry. EMC is an international investor relations firm with affiliates around the world. EMC is relationship-driven and results-oriented with the goal of seeking attractive emerging companies and concentrating its resources and efforts to serve a limited number of high-quality clients. For more information, visit EMC's website at www.emergingmarketsllc.com. Must Read OTC Markets/SEC policy on stock promotion and investor protection Policy on Stock Promotion Investor Protection SEC: Payments for Bullish Articles on Stocks Must Be Disclosed to Investorsttps://www.sec.gov/news/press-release/2017-79 Updated Investor Alert: Fraudulent Stock Promotions Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements, including information about management's view of the Company's future expectations, plans and prospects. In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. Factors that could cause results to differ include but are not limited to, successful performance of internal plans, product or services development and acceptance, the impact of competitive services and pricing, or general economic risks and uncertainties. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The Company takes no obligation to update or correct (i) its own forward-looking statements, except as required by law, or (ii) those prepared by third parties that are not paid for by the Company. DISCLAIMER Emerging Markets has been paid $178,000 from XPhyto Therapeutics Corp. View Full Disclaimer for Emerging Markets Consulting, LLC. Stay Connected | Get Updates by Industry Type > This email is never sent unsolicited. You have received this Newsmax email because you subscribed to it or someone forwarded it to you. To opt out, see the links below. TO ADVERTISE For information on advertising, please contact Newsmax Advertising Sales via email. TO SUBSCRIBE If this email has been forwarded to you and you would like to sign up, please click here. Remove your email address from our list or modify your profile. We respect your right to privacy. View our policy. This email was sent by: Newsmax.com 1501 Northpoint Parkway, Suite 104 West Palm Beach, FL 33407 USA DM230152 010504nacyue